Acorda Therapeutics Inc Buchwert je Aktie
Was ist das Buchwert je Aktie von Acorda Therapeutics Inc?
Buchwert je Aktie von Acorda Therapeutics Inc ist -8.21
Was ist die Definition von Buchwert je Aktie?
Der Buchwert pro Aktie ist das Vermögen eines Unternehmens abzüglich der Verbindlichkeiten geteilt durch die Anzahl der ausstehenden Aktien.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Buchwert je Aktie von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acorda Therapeutics Inc
Was macht Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Unternehmen mit buchwert je aktie ähnlich Acorda Therapeutics Inc
- Opto Circuits (India) hat Buchwert je Aktie von -8.45
- California Resources Corp hat Buchwert je Aktie von -8.41
- MBIA hat Buchwert je Aktie von -8.37
- Dynavision hat Buchwert je Aktie von -8.27
- Vivint Smart Home Inc hat Buchwert je Aktie von -8.24
- Rusoro Mining hat Buchwert je Aktie von -8.22
- Acorda Therapeutics Inc hat Buchwert je Aktie von -8.21
- Town Sports International hat Buchwert je Aktie von -8.11
- MDC Partners hat Buchwert je Aktie von -8.06
- Ansal Properties & Infrastructure hat Buchwert je Aktie von -8.05
- Lanesborough Real Estate Investment Trust hat Buchwert je Aktie von -8.04
- Mechel PJSC hat Buchwert je Aktie von -7.79
- Setco Automotive hat Buchwert je Aktie von -7.77